Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from UCB

Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE

BOSTON, SINGAPORE and HONG KONG, June 22, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: [6996 HK]), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today announced that it has entered into…

AAP

UCB Transforms Safety Operations with Veeva Safety Suite in Collaboration with ELIQUENT Life Sciences, Pinnaxis, and Daelight Solutions

WASHINGTON, June 12, 2026 /PRNewswire/ -- ELIQUENT Life Sciences ("ELIQUENT") today announced the June 1 go-live of Veeva Safety Suite at UCB. As one of the first organizations to adopt the complete suite, UCB is unifying its global safety operations in a transformation delivered through a strategic collaboration between Veeva,…

AAP

Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China

SHANGHAI and HONG KONG, June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today announced that China's National Medical Products Administration (NMPA)…

AAP

From analysis to the latest developments in health,
read the most diverse news in one place.

RBI tightens norms for re-appointment of directors on UCB boards

The Reserve Bank of India has introduced new rules for Urban Co-operative Banks. Directors can now serve for a maximum of ten years. Following this, a mandatory three-year cooling-off period is required before re-appointment. This measure aims to prevent directors from circumventing tenure limits. The new directions are effective immediately,…

The Economic Times

Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline

SHANGHAI and HONG KONG, May 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that Dr. Bing Hou has been appointed…

AAP

Belgian drugmaker UCB to invest $2B in suburban Atlanta plant, adding 330 jobs

Belgian pharmaceutical maker UCB says it will build a $2 billion drug manufacturing plant near Atlanta

The Independent UK

Your Guide to the 'Jury Duty' Season 2 Cast and Characters: Who's Who in 'Company Retreat'

Prime Video's wholesome prank show recruited actors from sitcoms like 'The Office,' 'Brooklyn Nine-Nine,' and more.

Marie Claire

Read news from The Economist, FT, and more,
with one subscription

$Bone-building drug which prevents fractures in people with osteoporosis approved for use in UK – here’s how it works$

Bone-building drug which prevents fractures in people with osteoporosis approved for use in UK – here’s how it works

A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of fractures. Abaloparatide’s approval could benefit more than 14,000 women in the UK who are at serious risk of bone fracture.

The Conversation

With an audacious title and Bowen Yang playing God, ‘Dicks: The Musical’ dares to be gonzo

You don’t expect to see a movie named “Dicks: The Musical” on the marquee and neither did its makers

The Independent UK

Here’s what Jaylen Brown told Deion Sanders during UCB visit with Colorado alum Derrick White

Jaylen Brown was able to have a quick conversation with head coach Deion Sanders while visiting the University of Colorado with his teammate Derrick White.

USA Today Sports Media Group

University College Birmingham bids to build 1,200 student bedrooms

Institute wants to regenerate its current old halls in city centre which were built in 1970s but need to be replaced

Birmingham Post

RBI comes out with four-tiered regulatory framework for urban cooperative banks

MUMBAI: The Reserve Bank of India (RBI) on Thursday announced a four-tiered regulatory framework for categorisation of Urban Co-operative Banks (UCBs).

The Times of India

In the neighbourhood of Cameroon legend Samuel Eto’o

The Cameroon star’s roots are in the impoverished community of New Bell, where they remember a prodigious child playing.

Al Jazeera

GMI wins brief to build new £10m university skills centre

New Birmingham centre will run range of courses in construction

Birmingham Post

Get all your
news in one place.

100's of premium titles.
One news app.

Birmingham Post

Former University College Birmingham building sold for residential conversion

London-based investor is eyeing seven-storey block to be transformed into city apartment complex

The Times of India

Urban co-operative banks to have 4-tiered regulatory framework: RBI

MUMBAI: The RBI on Tuesday said it has decided to adopt a simple four-tiered regulatory framework for urban co-operative banks (UCBs) based on size of deposits, with an aim to strengthen their financial soundness.

The Times of India

PMC Bank case fallout: RBI asks UCBs to make higher provisions for inter-bank exposures

MUMBAI: The Reserve Bank on Friday issued fresh provisioning norms for urban cooperative banks' inter-bank exposure as well as valuation of their perpetual non-cumulative preference shares and equity warrants, directing them to continue making provisions to the tune of 20 per cent for such exposures.

Benzinga

UCB's Rare Childhood Epilepsy Drug Scores FDA Approval

The FDA approved UCB SA's (OTC:UCBJY) drug to treat seizures associated with Lennox-Gastaut Syndrome (LGS), a rare form of childhood epilepsy. The drug, branded as Fintepla, is approved in the U.S. to treat another form of childhood-onset epilepsy, Davet Syndrome (DS), in patients aged two years and older. LGS causes cognitive dysfunction and…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study

UCB SA (OTC: UCBJF)

Benzinga

52 Biggest Movers From Yesterday

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.

Benzinga

35 Stocks Moving In Wednesday's Mid-Day Session

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.

Benzinga

Why Zogenix Shares Are Soaring Today

Zogenix Inc (NASDAQ: ZGNX) is trading significantly higher Wednesday morning after the company announced it received a proposal to be acquired by UCB for approximately $1.9 billion.

Benzinga

20 Stocks Moving in Wednesday's Pre-Market Session

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company.

Benzinga

UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights

Belgian-based UCB SA (OTC: UCBJF) has agreed to buy Zogenix Inc (NASDAQ: ZGNX), a U.S.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Reserve Bank of India

220 stories

University of Colorado

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.